Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2018-01-08 History
Report ID 31057
Drug Identification Number 02398427
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS
Packaging size 1 VIAL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-11-23
Estimated end date 2017-12-22
Actual end date 2017-12-20
Shortage status Resolved
Updated date 2018-01-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-01-08 French Compare
v5 2018-01-08 English Compare
v4 2017-12-15 French Compare
v3 2017-12-15 English Compare
v2 2017-11-28 French Compare
v1 2017-11-28 English Compare

Showing 1 to 6 of 6